Ποια είναι η τιμή για DelMar Pharmaceuticals, Inc. (DMPWW)

Η τιμή για DelMar Pharmaceuticals, Inc. (DMPWW) είναι $0.005

Ποια είναι η κεφαλαιοποίηση αγοράς για DelMar Pharmaceuticals, Inc. (DMPWW)

Η κεφαλαιοποίηση αγοράς για DelMar Pharmaceuticals, Inc. (DMPWW) είναι $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Ιστορικό Τιμών

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Έτος	Απόδοση
2024	79.76%
2023	-86.88%
2022	0.00%

Έτος

Απόδοση

2024

79.76%

2023

-86.88%

2022

0.00%

Εταιρεία	Τιμή μετοχής	Μεταβολή 1Έτ%	Χώρα
Vertex Pharmaceuticals Incorporated VRTX.US	$527.87	36.13%	US
Argenx SE ARGX.US	$873.57	37.02%	NL
Lonza Group AG LONN.SW	$736.38	8.73%	CH
UCB S.A. UCB.BR	$263.09	20.45%	BE
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-5.56%	KR

Εταιρεία

Τιμή μετοχής

Μεταβολή 1Έτ%

Χώρα